Stock AGRX AGILE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Market Closed - OTC Markets
Other stock markets
 20:16:29 03/05/2024 BST 		5-day change 1st Jan Change
0.384 USD -5.14% Intraday chart for Agile Therapeutics, Inc. -4.00% -80.31%
03-28 Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
03-28 Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Downgrades Agile Therapeutics to Hold From Buy
MT
Maxim Upgrades Agile Therapeutics to Buy From Hold With $5 Price Target
MT
HC Wainwright Cuts Price Target on Agile Therapeutics to $3 From $5, Maintains Buy Rating
MT
Maxim Upgrades Agile Therapeutics to Buy from Hold, Sets $1 Price Target
MT
HC Wainwright Raises Agile Therapeutics' Price Target to $5 From $2.50, Maintains Buy Rating
MT
Maxim Downgrades Agile Therapeutics to Hold From Buy
MT
Oppenheimer Adjusts Agile Therapeutics' Price Target to $1.50 From $4, Maintains Outperform Rating
MT
AGILE THERAPEUTICS : HC Wainwright Adjusts Agile Therapeutics PT to $3.50 From $7, Maintains Buy Rating
MT
AGILE THERAPEUTICS' : Price Target Trimmed to $5 From $6 by RBC on Equity Dilution; Outperform, Speculative Risk Maintained
MT
AGILE THERAPEUTICS : Oppenheimer Adjusts Price Target for Agile Therapeutics to $4 From $6, Maintains Outperform Rating
MT
AGILE THERAPEUTICS : Oppenheimer Adjusts Agile Therapeutics' Price Target to $6 From $10, Maintains Outperform Rating
MT
AGILE THERAPEUTICS : Oppenheimer Adjusts Agile Therapeutics PT to $10 From $12, Maintains Outperform Rating
MT
AGILE THERAPEUTICS : HC Wainwright Adjusts Agile Therapeutics' Price Target to $7 From $6, Keeps at Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGRX Stock
  4. News Agile Therapeutics, Inc.
  5. Analyst Reco.